7Baggers
Quarterly
Annual
    Unit: USD2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 2019-07-31 2019-04-30 2019-01-31 2018-10-31 2018-07-31 2018-04-30 2018-01-31 2017-10-31 2017-07-31 2017-04-30 2016-09-30 2015-12-31 2015-09-30 2015-06-30 2015-03-31 
      
    		                                       
      cash flows from operating activities:
    		                                       
      net income
    		-60,096,000 -52,226,000 -48,508,000 -42,267,000 -40,443,000 -44,649,000 -29,028,000 -27,650,000 -25,317,000 -26,305,000 -21,303,000 -22,257,000 -23,042,000 -24,113,000 -22,468,000 -19,649,000 -16,109,000 -14,956,000 -10,047,000 -10,427,000 -10,814,000 -6,584,000 -9,291,000 -5,903,000 -7,338,000 -8,526,000 -3,956,000 -3,304,000 -5,030,000 -657,000 -5,234,000 -4,986,000 -4,928,000 -4,202,000 -2,386,000 -5,659,000 -4,991,000 -9,012,000 -5,184,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                       
      depreciation and amortization
    		252,000 261,000 229,000 227,000 224,000 219,000 207,000 197,000 193,000 188,000 199,000 173,000 158,000 156,000 149,000 127,000 132,000 140,000 136,000 133,000 128,000 130,000 134,000 127,000 121,000 122,000 103,000 103,000 50,000 51,000 50,000 47,000 32,000  0 35,000 33,000 34,000 31,000 
      stock-based compensation expense
    		5,379,000 3,642,000 2,610,000 2,999,000 3,040,000 12,743,000 2,711,000 3,207,000 3,254,000 2,441,000 2,333,000 2,506,000 2,642,000 2,654,000 2,777,000 2,860,000 2,795,000 3,441,000 1,241,000 1,248,000 1,188,000 1,090,000 1,122,000 1,162,000 1,074,000 846,000 797,000 976,000 347,000           
      realized gain from sale of marketable securities
    		-587,000         55,000 -1,000 69,000 16,000 285,000 176,000 97,000 23,000 39,000 -76,000 -46,000 -70,000                   
      non cash operating lease expense
    		                                       
      amortization of premium on marketable securities
    		-7,000  1,000 5,000 5,000  5,000 21,000 62,000  212,000 287,000 391,000  657,000 671,000 753,000  110,000 69,000 68,000                   
      foreign currency exchange gain
    		485,000     164,000 -215,000   -279,000 -600,000 -1,165,000 426,000 854,000 432,000 252,000 14,000                       
      non-cash interest expense and amortization of issuance costs
    		3,453,000 2,948,000                                      
      fair value adjustment to derivative liability
    		1,100,000 1,600,000                                      
      impairment of right of use assets
    		                                       
      changes in operating assets and liabilities:
    		                                       
      research and development tax credit receivable
    		826,000   -1,068,000 -1,253,000 14,391,000 -2,106,000 -2,025,000 -2,084,000 -4,365,000 9,186,000 -3,567,000 -3,570,000 -3,724,000 5,775,000 -4,041,000 -3,211,000 -2,678,000 7,813,000 -2,140,000 4,462,000 -2,376,000 -2,828,000 1,483,000 -2,060,000 -2,474,000 -1,717,000 -1,611,000 919,000 -1,873,000 -986,000 -867,000 -530,000 703,000      
      accounts receivable
    		-1,926,000                                       
      inventory
    		                                       
      prepaid expenses and other assets
    		1,597,000 -1,281,000 -1,398,000 2,104,000 -783,000 -1,444,000 145,000 1,764,000 -1,003,000 2,250,000 790,000 1,715,000 1,935,000 -5,621,000 -1,240,000                         
      accounts payable
    		2,510,000 -1,392,000 779,000 -5,860,000 1,502,000 6,098,000 -1,941,000 55,000 108,000 3,018,000 -1,830,000 597,000 -678,000 1,459,000 -935,000 1,691,000 -528,000 1,332,000 -1,628,000 411,000 35,000 -1,137,000 691,000 -950,000 392,000 -214,000 -340,000 962,000 1,126,000 -331,000 687,000 -910,000 771,000 358,000 244,000 -148,000 -290,000 -218,000 1,011,000 
      accrued expenses and other liabilities
    		                                       
      deferred revenue
    		493,000                     -3,824,000 -1,577,000 -3,920,000 -3,369,000 -2,926,000 -3,890,000 -5,593,000 -3,718,000 -4,573,000          
      net cash from operating activities
    		-54,502,000 -40,364,000 -32,681,000 -39,642,000 -40,220,000 -15,105,000 -27,571,000 -19,825,000 -26,730,000 -22,636,000 -9,289,000 -20,594,000 -22,742,000 -26,789,000 -14,065,000 -19,545,000 -17,735,000 -11,045,000 -7,586,000 -7,952,000 -3,588,000 -12,618,000 -13,109,000 -7,814,000 -11,275,000 -10,511,000 -10,856,000 -8,786,000 -6,212,000 -5,955,000 28,220,000 -7,259,000 -4,448,000 -2,641,000 -1,616,000 -5,067,000 -5,306,000 -6,441,000 -4,049,000 
      capex
    		-290,000 -281,000 -24,000 -108,000 -21,000 -15,000 -19,000 -2,000 -6,000 -69,000 -15,000 -192,000 -920,000 -86,000 -202,000 -356,000 -287,000 -33,000 -14,000 -13,000 -22,000 -8,000 0 -114,000 -51,000 -275,000 -20,000 -221,000 -465,000 -1,084,000 -182,000 -51,000 -110,000 0 0 -379,000 -21,000 -79,000 -180,000 
      free cash flows
    		-54,792,000 -40,645,000 -32,705,000 -39,750,000 -40,241,000 -15,120,000 -27,590,000 -19,827,000 -26,736,000 -22,705,000 -9,304,000 -20,786,000 -23,662,000 -26,875,000 -14,267,000 -19,901,000 -18,022,000 -11,078,000 -7,600,000 -7,965,000 -3,610,000 -12,626,000 -13,109,000 -7,928,000 -11,326,000 -10,786,000 -10,876,000 -9,007,000 -6,677,000 -7,039,000 28,038,000 -7,310,000 -4,558,000 -2,641,000 -1,616,000 -5,446,000 -5,327,000 -6,520,000 -4,229,000 
      cash flows from investing activities:
    		                                       
      purchases of marketable securities
    		-19,979,000  -6,563,000 -1,000 -983,000  -18,150,000 -3,770,000 -25,767,000  -53,655,000 0 -10,102,000  -32,720,000 -32,659,000 -19,036,000  -7,472,000 -9,535,000 -9,807,000                   
      sales and maturities of marketable securities
    		41,677,000  15,207,000 48,876,000 38,230,000  11,558,000 32,531,000 45,386,000  51,153,000 20,290,000 41,066,000  45,824,000 50,658,000 34,204,000  14,431,000 15,919,000 15,342,000                   
      acquisition of property and equipment
    		-290,000 -281,000 -24,000 -108,000 -21,000 -15,000 -19,000 -2,000 -6,000 -69,000 -15,000 -192,000 -920,000 -86,000 -202,000 -356,000 -287,000 -33,000 -14,000 -13,000 -22,000 -8,000 0 -114,000 -98,000 -275,000 -20,000 -221,000 -565,000 -1,084,000 -182,000 -51,000 -110,000       
      disposal of property and equipment
    		                                       
      capitalized website development costs
    		-147,000 -234,000 -103,000 -94,000 -64,000                                   
      net cash from investing activities
    		21,261,000 -3,328,000 8,517,000 48,673,000 37,162,000 -126,186,000 -6,702,000 28,556,000 19,613,000 -6,210,000 -2,517,000 20,098,000 30,044,000 12,434,000 12,902,000 17,643,000 14,881,000 -166,483,000 6,945,000 6,371,000 5,513,000 10,027,000 9,770,000 -1,514,000 -1,530,000 -14,047,000 -54,589,000 -221,000 -565,000 -1,084,000 -182,000 -51,000 -110,000 -7,000 0 -1,094,000 -21,000 -79,000 -180,000 
      cash flows from financing activities:
    		                                       
      proceeds from sale of convertible notes
    		                                       
      proceeds from the royalty agreement
    		21,921,000                                       
      issuance of common stock, net of issuance costs of 0.5 million
    		                                       
      issuance of pre-funded warrants
    		                                       
      issuance of common stock from equity incentive plans
    		595,000 1,849,000 632,000 295,000 3,000,000 30,000 284,000 128,000 204,000 -33,000 146,000 168,000 168,000 138,000 772,000 63,000 608,000 1,374,000 55,000 60,000 46,000 2,000 44,000 138,000 32,000               
      issuance of common stock from employee stock purchase plan
    		694,000                                       
      net cash from financing activities
    		23,210,000 4,659,000 151,773,000 295,000 3,000,000 150,098,000 284,000 128,000 204,000 -33,000 57,813,000 168,000 168,000 138,000 772,000 63,000 608,000 210,308,000 1,703,000 60,000 46,000 1,000 45,000 138,000 11,400,000 155,000 56,000 82,784,000 4,948,000 -13,000 -52,000   0 5,000 6,000 -176,000 68,720,000 3,513,000 
      effect of exchange rate changes
    		                                       
      net increase in cash, cash equivalents and restricted cash
    		-7,308,000                                       
      cash, cash equivalents and restricted cash at beginning of the period
    		                                       
      cash, cash equivalents and restricted cash at end of the period
    		                                       
      less: restricted cash in other assets
    		                                       
      cash and cash equivalents
    		124,304,000                                       
      supplemental disclosure of non-cash activities
    		                                       
      lease liabilities arising from obtaining right of use assets
    		                                       
      property and equipment included in accounts payable and accrued expenses
    		                                       
      accrued debt issuance costs
    		                                       
      cash flows from operating activities
    		                                       
      non-cash operating lease expense
    		218,000     -1,000 2,000 -19,000 6,000 32,000 10,000 19,000 23,000 26,000 107,000 24,000 22,000 89,000 8,000 9,000 8,000                   
      accrued expenses
    		-8,199,000 8,115,000 3,053,000 5,037,000 -1,776,000 -2,435,000 2,870,000 4,014,000 -1,240,000 231,000 1,715,000 1,029,000 -1,043,000 751,000 505,000 217,000 -1,001,000 1,522,000 -1,874,000 797,000 538,000 718,000 -202,000 553,000 -1,117,000 2,248,000 351,000 -91,000 157,000 800,000 -33,000 550,000 -185,000 -371,000 -282,000 37,000 -394,000   
      cash flows from investing activities
    		                                       
      cash flows from financing activities
    		                                       
      effect of exchange rate changes on cash and cash equivalents
    		2,723,000 3,364,000 -1,249,000 407,000 117,000 -74,000 -621,000 -602,000 84,000 68,000 457,000 1,050,000 -339,000 -628,000 -523,000 -13,000 -3,000 85,000 491,000 -319,000 254,000 -236,000 190,000 802,000 -494,000 64,000 618,000 -731,000 -1,156,000           
      cash, cash equivalents and restricted cash at beginning of period
    		132,272,000                                       
      cash, cash equivalents and restricted cash at end of period
    		124,964,000                                       
      supplemental disclosures of non-cash activities:
    		                                       
      right of use assets obtained in exchange for operating lease liabilities
    		725,000 458,000 0       0 0 0 1,192,000 0                          
      reconciliation of cash, cash equivalents and restricted cash:
    		                                       
      restricted cash, long-term
    		660,000                                       
      total cash, cash equivalents and restricted cash
    		124,964,000                                       
      realized (gain) income from sale of marketable securities
    		     -195,000 -221,000 -595,000 -314,000                               
      amortization of premium on available for sale securities
    		                                       
      other receivables
    		                                       
      purchases of available for sale securities
    		                     -4,683,000 -2,553,000 -22,915,000 -19,646,000 -24,470,000              
      sales and maturities of available for sale securities
    		                     14,718,000 12,323,000 21,515,000 18,214,000               
      issuance costs associated with the royalty agreement
    		                                       
      issuance of common stock, net of offering expenses
    		 0                208,934,000    0     0             
      net increase in cash and cash equivalents
    		 -35,669,000 126,360,000 9,733,000 59,000 8,733,000 -34,610,000 8,257,000 -6,829,000 -28,811,000 46,464,000 722,000 7,131,000 -14,845,000 -914,000 -1,852,000 -2,249,000 32,865,000 1,553,000 -1,840,000 2,225,000 -2,826,000 -3,104,000   -24,339,000 -64,771,000   -7,623,000    -2,548,000 -1,611,000     
      cash and cash equivalents and restricted cash at beginning of year
    		                                       
      cash and cash equivalents and restricted cash at end of year
    		                                       
      supplemental disclosures of cash flow information:
    		                                       
      website development costs included in accounts payable
    		                                       
      non-cash operating lease benefit
    		                                       
      foreign currency exchange loss
    		                                       
      research and development tax credit
    		                                       
      proceeds from royalty agreement
    		                                       
      issuance costs associated with royalty agreement
    		                                       
      realized (gain) from sale of marketable securities
    		   -649,000 -317,000                                   
      non-cash operating lease (benefit) expense
    		   -45,000 -5,000                                   
      foreign currency exchange (gain) loss
    		        -395,000         -133,000 -273,000 264,000 -432,000                   
      cash and cash equivalents at beginning of period
    		   0 31,789,000  0 0 56,238,000  0 0 30,732,000  0 0 50,592,000  0 0 15,789,000  0 0 32,006,000  0 0 51,055,000  0 0 30,950,000  0  0 0 3,897,000 
      cash and cash equivalents at end of period
    		   9,733,000 31,848,000  -34,610,000 8,257,000 49,409,000  46,464,000 722,000 37,863,000  -914,000 -1,852,000 48,343,000  1,553,000 -1,840,000 18,014,000  -3,104,000 -8,388,000 30,107,000  -64,771,000 73,046,000 48,070,000  30,550,000 1,672,000 26,456,000  -1,611,000  -5,503,000 62,200,000 3,181,000 
      foreign currency exchange
    		    -414,000                                   
      cash and cash equivalents, beginning year
    		                                       
      cash and cash equivalents, end of year
    		                                       
      website development costs
    		      -91,000                                 
      issuance of common stock, net of offering expenses of 0.3 million
    		                                       
      issuance of pre-funded warrants, net of offering expenses
    		                                       
      property and equipment included in accounts payable and accrued expenses:
    		           -12,000 144,000  -20,000                         
      finance lease principal payments
    		                                       
      prepaid expenses and other current assets
    		                -625,000 -257,000 -2,996,000 1,730,000 1,301,000 -925,000 -972,000 224,000 561,000 496,000 -1,958,000 -448,000 -69,000 460,000 -570,000 -551,000 -85,000 608,000 533,000 349,000 43,000 -487,000 -437,000 
      other assets
    		                             0     0 -58,000    
      acquisition of property and equipment in accounts payable
    		                        47,000    100,000           
      grants and other receivables
    		                             38,000 871,000         
      capital leases
    		                             0 0 0 513,000       
      realized (gain) from available for sale securities
    		                                       
      amortization of right of use assets
    		                      145,000 135,000 138,000               
      amortization of discount/premium on available for sale securities
    		                      57,000 44,000 35,000               
      lease obligations
    		                      -145,000 -134,000 -137,000               
      capital lease principal payments
    		                      1,000 0 -54,000 -54,000 -51,000 -52,000 -52,000 -50,000 -52,000         
      realized (gain) income from available for sale securities
    		                       -100,000 -29,000               
      foreign currency remeasurement (gain) loss
    		                              -531,000 -1,000 32,000       
      issuance of common stock, net of 123 of offering expenses
    		                       0 11,422,000               
      foreign currency remeasurement loss
    		                        454,000 -60,000 -246,000 220,000 6,000           
      net decrease in cash and cash equivalents
    		                        -1,899,000    -2,985,000   1,672,000 -4,494,000      -716,000 
      supplemental disclosures of non-cash financing activities
    		                                       
      changes in operating assets and liabilities, net of changes from business acquired:
    		                                       
      cash acquired in transaction
    		                                       
      proceeds from issuance of common stock, net of issuance costs of 4,390 in the year ended april 30, 2019
    		                                       
      proceeds from issuance of common stock from exercise of stock options
    		                                       
      conversion of preferred stock and ordinary shares to common stock
    		                                       
      sales of available for sale securities
    		                                       
      issuance of common stock from stock option exercises
    		                          107,000             
      issuance of common stock
    		                            5,000,000  0         
      proceeds from issuance of common stock
    		                                 0  0 -176,000 67,964,000 120,000 
      proceeds from issuance of series b preferred stock, net of issuance costs
    		                                       
      stock-based compensation
    		                              285,000 273,000 221,000       
      effect of exchange rate changes on cash
    		                              2,564,000 -69,000 64,000 100,000      
      conversion of preferred stock to common stock
    		                                   0 0   
      due to related parties
    		                                       
      grants receivable
    		                                224,000 -7,000      
      depreciation expense
    		                                       
      share-based compensation expense
    		                                       
      foreign currency exchange rate gain
    		                                       
      cash acquired in carbylan transaction
    		                                       
      purchases of property and equipment
    		                                       
      proceeds from issuance of series a preferred stock, net of issuance costs
    		                                       
      cash paid for taxes
    		                                       
      foreign currency remeasurement gain
    		                                       
      proceeds from issuance of redeemable convertible preferred stock
    		                                       
      gain on sale of property and equipment
    		                                  0     
      stock based compensation expense
    		                                  282,000  289,000 37,000 118,000 
      change in fair value of preferred stock warrant liability and derivative liability
    		                                   0 0 -2,000 -518,000 
      non-cash interest expense
    		                                  0 37,000 35,000 73,000 84,000 
      amortization of loan and convertible promissory notes discount
    		                                  0 7,000 15,000 51,000 707,000 
      loss on extinguishment of loans payable
    		                                       
      loss on extinguishment of convertible promissory notes
    		                                   0 0   
      impairment of long-lived assets
    		                                  0     
      deferred licensing revenue
    		                                  -7,000 -8,000 -7,000 -7,000 -7,000 
      purchase of property and equipment
    		                                  0 -379,000 -21,000 -79,000 -180,000 
      sale of property and equipment
    		                                  0     
      proceeds from issuance of common stock upon exercise of options
    		                                  5,000 6,000 0   
      proceeds from convertible promissory notes
    		                                     0 4,000,000 
      repayment of loan payable
    		                                  0     
      supplemental cash flow information
    		                                       
      cash paid for interest
    		                                  0 135,000 0 1,000 44,000 
      supplemental disclosures of non-cash investing activities
    		                                       
      transfer of long-term deposits to property and equipment
    		                                  0     
      conversion of preferred stock warrants to common stock warrants
    		                                   0 0   
      derivative related to convertible promissory notes at issuance
    		                                       
      beneficial conversion feature for convertible promissory notes
    		                                       
      loss on extinguishment of loan payable
    		                                       
      increase accrual of deferred public offering costs
    		                                       
      deferred public offering costs
    		                                      -607,000 
      property and equipment additions in accounts payable and accrued expenses
    		                                       
      accrual of deferred public offering costs
    		                                       
      stock based compensation
    		                                       
      deposit for leasehold improvements
    		                                       
      proceeds from issuance of convertible preferred stock
    		                                       
      proceeds from loans payable
    		                                       
      repayment of loans payable
    		                                       
      net increase/(decrease) in cash and cash equivalents
    		                                   -6,155,000 -5,503,000   
      cash and cash equivalents at beginning of year
    		                                       
      cash and cash equivalents at end of year
    		                                       
      issuance of preferred stock warrants
    		                                       
      increase of accrual for deferred public offering costs
    		                                       
      increase of derivative related to convertible promissory notes
    		                                       
      increase of beneficial conversion feature for convertible promissory notes
    		                                   0 0   
      increase of derivative related to convertible promissory notes at issuance
    		                                    0   
      accruals
    		                                      146,000 
      derivative related to convertible promissory notes upon issuance
    		                                      1,196,000 
      beneficial conversion feature of convertible promissory notes
    		                                      158,000 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.